| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/20/2008 | US20080069941 Animals for Conserving N-3 Highly Unsaturated Fatty Acids |
| 03/20/2008 | US20080069846 Gene coding, gene expression, purification; used as detergents, cosmetics, leather processing, softening for food, meats, animal feeds |
| 03/20/2008 | US20080069840 Immunotherapy ; antigen codes Dna vaccine; antitumor agents |
| 03/20/2008 | US20080069837 Composition and method for treating cancer using herpes virus |
| 03/20/2008 | US20080069836 Method of using adenoviral vectors with increased immunogenicity in vivo |
| 03/20/2008 | US20080069833 Anticancer agents; mixture of fusion protein and yeast vehicle |
| 03/20/2008 | US20080069831 Vaccines; fusion protein; induce immunology response |
| 03/20/2008 | US20080069829 Ability to bind to antibodies; diagnosis of allergies |
| 03/20/2008 | US20080069825 Multiple CpG oligodeoxynucleotides and their use to induce an immune response |
| 03/20/2008 | US20080069821 Avian pandemic; immunogens; antibodies; immunology |
| 03/20/2008 | US20080069819 Method and composition for detecting cancer by means of detection of epstein-barr virus nuclear antigen 2 coactivator p100 |
| 03/20/2008 | US20080069816 Carcinoembryonic antigen (CEA); utilizes crystallographic structural data to select immunoglobulin framework having maximum structural overlap non-human donor molecule |
| 03/20/2008 | US20080069804 Polynucleotides; RNA; helper cells |
| 03/20/2008 | US20080069803 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions vectors |
| 03/20/2008 | US20080069802 Glycosylated adenovirus particles; capsids; tumor suppressors; gene therapy |
| 03/20/2008 | US20080069799 Use of il-22 for the treatment of conditions of metabolic disorders |
| 03/20/2008 | US20080069798 Hyperlipidemia, obesity, hyperinsulinemia and diabetes; gene therapy |
| 03/20/2008 | US20080069791 Administering composition of a polynucleotide, a polypeptide encoded by the nucleic acid and a compound which binds to an antibody which recognizes the polypeptide or binds to an IL- 15 receptor alpha chain; using a transgenic animal comprising an IL-15 polynucleotide |
| 03/20/2008 | US20080069775 Administering anti-idiotype antibody or antibody fragment comprising heavy chain variable region sequences and light chain variable region sequences conjugated to a soluble immunogenic carrier protein |
| 03/20/2008 | US20080069773 Novel Sodium Channel |
| 03/20/2008 | US20080069772 Treatment of transformed or infected biological cells |
| 03/20/2008 | US20080069770 Monoclonal antibodies; used to modulate the immune system; no modulation of the totality of the T-cell population but only of the sub-assembly of T-cells expressing the beta sub-family specific to the T-cell receptors; used for organ transplant rejection |
| 03/20/2008 | DE10080167B4 Medikament zur Hemmung der Expression eines vorgegebenen Gens Medicament for inhibiting the expression of a given gene |
| 03/20/2008 | CA2842966A1 Cell culture improvements |
| 03/20/2008 | CA2842964A1 Cell culture improvements |
| 03/20/2008 | CA2842959A1 Cell culture improvements |
| 03/20/2008 | CA2672921A1 Removal of molecular assay interferences for nucleic acids employing buffered solutions of chaotropes |
| 03/20/2008 | CA2666819A1 Mammalian oocyte development competency granulosa markers and uses thereof |
| 03/20/2008 | CA2664318A1 Long lasting drug formulations |
| 03/20/2008 | CA2664175A1 Animal model for the selection and validation of agents active against pulmonary emphysema and colorectal cancer |
| 03/20/2008 | CA2663498A1 Compositions and methods to prevent cancer with cupredoxins |
| 03/20/2008 | CA2663295A1 Alphavirus replicon particles matched to protein antigens as immunological adjuvants |
| 03/20/2008 | CA2663146A1 Expression of tgf-beta in plastids |
| 03/20/2008 | CA2663045A1 Nucleic acids for expressing a polynucleotide of interest in mammalian cancer cells |
| 03/20/2008 | CA2662931A1 Trace mrna amplification method and use thereof |
| 03/20/2008 | CA2662560A1 Oligonucleotide non-viral delivery systems |
| 03/19/2008 | EP1901070A2 Method and composition for detecting cancer by means of detection of Epstein-Barr virus nuclear antigen 2 coactivator p100 |
| 03/19/2008 | EP1901064A2 Method for measuring skin absorbability |
| 03/19/2008 | EP1900827A2 Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasia |
| 03/19/2008 | EP1900823A2 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents |
| 03/19/2008 | EP1900821A1 Process for production of l-amino acid |
| 03/19/2008 | EP1900820A1 Nuclear transport agent and method for producing said agent |
| 03/19/2008 | EP1900819A1 Animal model for the selection and validation of agents active against pulmonary emphysema and colorectal cancer |
| 03/19/2008 | EP1900818A2 Neisserial antigens |
| 03/19/2008 | EP1900817A1 A bentazon and sulfonylurea herbicide-resistant gene cyp81a6 of rice |
| 03/19/2008 | EP1900816A2 GL50 molecules and uses therefor |
| 03/19/2008 | EP1900815A2 In vivo production of small interfering RNAs that mediate gene silencing |
| 03/19/2008 | EP1900814A1 sc(Fv)2 SITE-DIRECTED MUTANT |
| 03/19/2008 | EP1900813A1 Novel physiological substance nesfatin, substance relevant thereto, and use of the substances |
| 03/19/2008 | EP1900754A1 Fusion proteins comprising two lgG binding domains of streptococcal protein G |
| 03/19/2008 | EP1900753A2 Method of administering therapeutic polypeptides, and polypeptides therefor |
| 03/19/2008 | EP1900749A1 Nucleic acids for expressing a polynucleotide of interest in mammalian cancer cells |
| 03/19/2008 | EP1900377A1 Inhibitors of GPR87 for cancer therapy |
| 03/19/2008 | EP1900376A2 Synergistic inhibition of HIV-1 fusion and attachment, compsitions and antobodies thereto |
| 03/19/2008 | EP1900360A1 Homer a new target of treating psychiatric disorders |
| 03/19/2008 | EP1899860A1 Method of processing and/or genome mapping of ditag sequences |
| 03/19/2008 | EP1899729A2 Target substance-capturing body, device for capturing target substance, and instrument, kit and method for detecting target substance by use of them |
| 03/19/2008 | EP1899727A1 Probe-immobilized carrier storing manufacturing condition data and manufacturing method and apparatus thereof, detecting method of target substance by use of the probe-immobilized carrier, and measuring apparatus, recording medium, kit and system for use in the detecting method |
| 03/19/2008 | EP1899474A1 Use of lepa for improving the accuracy of protein synthesis in vitro |
| 03/19/2008 | EP1899470A2 System for rapid production of high-titer and replication-competent adenovirus-free recombinant adenovirus vectors |
| 03/19/2008 | EP1899469A2 Nucleotide sequences mediating plant male fertility and method of using same |
| 03/19/2008 | EP1899468A1 siRNA FOR INHIBITING IL-6 EXPRESSION AND COMPOSITION CONTAINING THEM |
| 03/19/2008 | EP1899467A2 Modified oligoribonucleotide analogs with enhances immunostimulatory activity |
| 03/19/2008 | EP1899466A2 Sirna molecules for treatment of blood vessels |
| 03/19/2008 | EP1899465A2 Iterated branching reaction pathways via nucleic acid-mediated chemistry |
| 03/19/2008 | EP1899464A2 Method of selecting polypeptides |
| 03/19/2008 | EP1899463A2 Biomarkers for evaluating likelihood of tumor sensitivity to an mtor inhibitor |
| 03/19/2008 | EP1899378A2 Il-1 beta binding antibodies and fragments thereof |
| 03/19/2008 | EP1899367A1 Mutant allergen(s) |
| 03/19/2008 | EP1899366A2 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 03/19/2008 | EP1898956A2 Anti-tumoral compositions and methods |
| 03/19/2008 | EP1898936A1 Method of cancer treatment using sirna silencing |
| 03/19/2008 | EP1898701A1 Delivery of active proteins to the central nervous system using phage vectors |
| 03/19/2008 | EP1725216A4 Immunoliposome-nucleic acid amplication (ilnaa) assay |
| 03/19/2008 | EP1713923B1 Enzymatic asymmetric decarboxylation of disubstituted malonic acids |
| 03/19/2008 | EP1709174A4 A polynucleotide associated with a type ii diabetes mellitus comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for analyzing polynucleotide using the same |
| 03/19/2008 | EP1708558A4 Proteins which confer biotic and abiotic stress resistance in plants |
| 03/19/2008 | EP1700916B1 Novel centromeric protein shugoshin |
| 03/19/2008 | EP1636354A4 Erk7 and erk8, novel diagnostic markers for cancer |
| 03/19/2008 | EP1613745B1 L-carnitin dehydrogenases, their derivatives and method for producing substituted (s) alkanols |
| 03/19/2008 | EP1590435B1 Depletion of endogenous primordial germ cels in avian species |
| 03/19/2008 | EP1535996B1 Glucose dehydrogenase |
| 03/19/2008 | EP1523301B1 Delivery system for pharmaceutical agents |
| 03/19/2008 | EP1517990B1 Isolation of nucleic acids using a polycationic polymer as precipitation agent |
| 03/19/2008 | EP1513545B1 Methods and means to promote gut absorption |
| 03/19/2008 | EP1472339B1 A process for identifying a novel target for use for the development of therapeutic modalities and drugs effective against tuberculosis |
| 03/19/2008 | EP1428880B1 Kidney-specific urate transporter and gene thereof |
| 03/19/2008 | EP1383556B9 INJECTION DEVICE FOR ADMINISTERING mRNA |
| 03/19/2008 | EP1330650A4 Method and apparatus for reading reporter labeled beads |
| 03/19/2008 | EP1326980B1 Methods of treatment using wisp polypeptides |
| 03/19/2008 | EP1012240B1 Cancer immunotherapy with semi-allogeneic cells |
| 03/19/2008 | EP1009831B1 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses |
| 03/19/2008 | EP1006195B1 INFECTIOUS VECTORS AND CLONES OF PLANTS DERIVED FROM THE TURNIP MOSAIC VIRUS (TuMV) |
| 03/19/2008 | EP0979279B1 Hemoglobin mutants with reduced nitric oxide scavenging |
| 03/19/2008 | EP0946716B1 Waxy wheat starch types having waxy proteins in granule |
| 03/19/2008 | EP0935665B1 Encapsulation of polypeptides within the starch matrix |
| 03/19/2008 | EP0929564B1 High level expression of proteins |
| 03/19/2008 | EP0920527B1 SYNTHESIS OF beta-LACTAM ANTIBACTERIALS USING SOLUBLE SIDE CHAIN ESTERS AND ENZYME ACYLASE |
| 03/19/2008 | EP0910647B1 Human dnase i hyperactive variants |
| 03/19/2008 | CN101147062A Probe array and process for producing the same |